Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001411260 | SCV001613319 | likely benign | Hypertrophic cardiomyopathy | 2023-11-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002322412 | SCV002610322 | likely benign | Cardiovascular phenotype | 2022-01-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002488227 | SCV002799262 | likely benign | Hypertrophic cardiomyopathy 1; Myopathy, myosin storage, autosomal recessive; Myosin storage myopathy; Congenital myopathy with fiber type disproportion; Dilated cardiomyopathy 1S; MYH7-related skeletal myopathy | 2021-12-03 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004006924 | SCV004817255 | likely benign | Cardiomyopathy | 2023-02-24 | criteria provided, single submitter | clinical testing |